IL18BP and neoplasm: Importantly, combined treatment with IL-18BP and doxorubicin significantly increased macrophage infiltration and activated macrophages with M1-polarity compared to single treatment (Fig. 5a, b) and resulted in significantly inhibition of tumor growth (Fig. 5c).